Fairmount Healthcare Fund L.P.

CIK 1686157 · last filed 2023-11-01

Fairmount Healthcare Fund L.P. is a corporate insider who has filed 3 SEC Form 4 insider transactions across 2 companies since 2020. The most recent filing, for VRDN, was dated Nov 1, 2023. The firm reports its address in West Conshohocken, PA. 16 SEC filings were submitted jointly with Fairmount Funds Management LLC.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Disclosed Exposure

$0

Companies

2

Total Filings

3

Lifetime Open-Market Net

$0

Filer Profile

Reported Address

200 BARR HARBOR DRIVE
SUITE 400
WEST CONSHOHOCKEN, PA 19428

Phone

(267) 760-4066

State of Incorporation

Related Filers

Fairmount Funds Management LLC — 16 joint filings, latest 2024-04-01

Fairmount Healthcare Fund II L.P. — 16 joint filings, latest 2024-04-01

Fairmount Healthcare Fund GP LLC — 8 joint filings, latest 2024-04-01

Fairmount Healthcare Fund II GP LLC — 8 joint filings, latest 2024-04-01

Peter Evan Harwin — 7 joint filings, latest 2024-04-01

Tomas Kiselak — 7 joint filings, latest 2024-04-01

Fairmount Healthcare Co-Invest III L.P. — same reported address

Fairmount Healthcare Co-Invest IV L.P. — same reported address

Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.

Symbol	Role	Shares	Price	Disclosed Exposure	Lifetime OM Net	Filings	Latest Filed
VRDN	Director	—	$22.92	—	$0	1	2023-11-01
Viridian Therapeutics, Inc.\DE (MGEN) Delisted	Director	29,233	—	—	$0	2	2020-10-30

Recent Filings

3 filings

Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.

Filed	Symbol	Action	Net Shares	Net $	Link
2023-11-01	VRDN	Grant (A)	—	$0	EDGAR
2020-10-30	Viridian Therapeutics, Inc.\DE (MGEN) Delisted	Buy (P)	—	$0	EDGAR
2020-10-29	Viridian Therapeutics, Inc.\DE (MGEN) Delisted	Other (J)	+2,631,965	$0	EDGAR

Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.